{"id":109974,"date":"2014-02-19T17:44:36","date_gmt":"2014-02-19T22:44:36","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/gene-therapy-shows-promise-for-treating-heart-attack-victims.php"},"modified":"2014-02-19T17:44:36","modified_gmt":"2014-02-19T22:44:36","slug":"gene-therapy-shows-promise-for-treating-heart-attack-victims","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/gene-therapy\/gene-therapy-shows-promise-for-treating-heart-attack-victims.php","title":{"rendered":"Gene Therapy Shows Promise for Treating Heart Attack Victims"},"content":{"rendered":"<p><p>      Injections of a normally silent gene sparked recovery in pigs      induced to have heart attacks          <\/p>\n<p>      Thinkstock\/iStock    <\/p>\n<p>      When a heart attack brings blood flow to a screeching halt,      thats only the first assault on our fist-size organ. Among      survivors, the recovery itself fuels more permanent damage to      the heart. Scar tissue can harden once-flexible heart muscle,      making it less elastic. And as tentacles of this tissue creep      over the aorta the heart muscle can no longer fully contract.      This long-term damage can minimize the amount of oxygen-rich      blood sent throughout the body, which can send patients      spiraling into heart failure.            Heart transplants are one way to circumvent these scar tissue      issues, but donor hearts are always in short supply. Devising      other truly effective solutions has long eluded researchers.      A form of gene therapy, however, is now showing promise in      pigs.            It turns out that a normally silent gene called Cyclin      A2, or CCNA2, can be coaxed into action to      combat the formation of scar tissue in pigs that suffer a      heart attack. This treatment sparked regeneration of heart      muscle cells in pigs as well as improvements in the volume of      blood pushed out with every beat. The finding is published in      the February 19 issue of Science Translational      Medicine.            Gene therapy, the authors hope, may one day join stem cell      treatments as a contender for transforming the way doctors      treat heart failure. Stem cellbased therapies have already      resulted in more healthy tissue and decreased scar mass in      human clinical trials as well as small improvements in how      much blood the heart can pump from one chamber to another.      But as Scientific American       reported in April 2013, many questions remain about which      stem cells to use and how to prepare them.            For this study, researchers randomly assigned 18 pigs      recovering from heart attacks to either receive injections of      the gene expressed under a promoter (which would force it to      be expressed) or the same solution without the gene. Pigs      treated with the gene had greater success pushing out blood      with each heartbeat, but also produced a greater number of      heart muscle cells. These findings echo the teams earlier      heart regeneration successes in mice and rats.            The researchers replicated their findings in a petri dish and      watched adult porcine heart muscle cells treated with the      same regimen of gene therapy undergo complete cell division      in the dishdemonstrating under a microscope how the heart      cells were dividing and thriving with the gene therapy. This      new approach mimics the kind of regeneration we see in the            newt and zebra fish, says lead author Hina Chaudhry, the      director of cardiovascular regenerative medicine at The Mount      Sinai Hospital in New York City.            If the technique proves successful in humans, it could boost      patient recovery rates by helping strengthen heart muscles      and improving blood flow, all while giving a needed lift to      gene therapy research, which has been slow to gain momentum      in the U.S. In 1999 Jesse Gelsinger, 18, died after a gene      therapy experiment cost him his life. The virus used to      deliver a gene that would potentially control his rare      digestive disorder fueled a massive and fatal immune      reaction. That highly publicized case, along with other gene      therapy missteps, put a pall on the field.            Chaudhry says that her team is proceeding with caution and      plans to be careful when administering this treatment to      patient populations. For patients who have a large heart      attack who are at risk of heart failure, I think the therapy      is going to be very beneficial, she says. If you have a      small heart attack, it probably wont make as much of a      difference in overall survival because of advances with      todays medicines. As more researchers look to gene therapy      for previously intractable human conditions, a success with      heart attack treatments could send ripples throughout the      field.                      <\/p>\n<p>       2014 Scientific      American, a Division of Nature America, Inc.    <\/p>\n<p>      View Mobile Site All      Rights Reserved.    <\/p>\n<p>        Give a 1 year subscription as low as $14.99      <\/p>\n<p>        Subscribe Now >>      <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Read the rest here: <\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.scientificamerican.com\/article\/gene-therapy-shows-promise-for-treating-heart-attack-victims\/\" title=\"Gene Therapy Shows Promise for Treating Heart Attack Victims\">Gene Therapy Shows Promise for Treating Heart Attack Victims<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Injections of a normally silent gene sparked recovery in pigs induced to have heart attacks Thinkstock\/iStock When a heart attack brings blood flow to a screeching halt, thats only the first assault on our fist-size organ.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/gene-therapy\/gene-therapy-shows-promise-for-treating-heart-attack-victims.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[24],"tags":[],"class_list":["post-109974","post","type-post","status-publish","format-standard","hentry","category-gene-therapy"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/109974"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=109974"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/109974\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=109974"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=109974"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=109974"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}